Truist Financial’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-23,293
Closed -$478K – 2643
2022
Q4
$478K Buy
+23,293
New +$411K ﹤0.01% 1986
2021
Q4
– Sell
-9,337
Closed -$356K – 2820
2021
Q3
$356K Sell
9,337
-2,888
-24% -$115K ﹤0.01% 2228
2021
Q2
$490K Buy
+12,225
New +$517K ﹤0.01% 2068

Other funds holding OFIX

Truist Financial's OFIX Position: Q1 2023 in Review

Truist Financial sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 23,293 shares — an estimated $478K sold.

Truist Financial first reported a position in OFIX in Q2 2021 and held it in 3 quarters. The position peaked at $490K in Q2 2021. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

  • Truist Financial reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
  • Truist Financial sold 23,293 Orthofix Medical shares in Q1 2023, an estimated $478K.
  • Truist Financial first reported a position in Orthofix Medical in Q2 2021 and held it in 3 quarters.
  • Truist Financial's Orthofix Medical position peaked at $490K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Truist Financial's 13F filing for Q1 2023, filed 5 May 2023.